Transfusion disposables and excellence in Clinical (tube feed) Nutrition
In the Netherlands and Europe, Fresenius Kabi Emmer-Compascuum occupies an unique position when it comes to efficient and highly international safety standards regarding transfusion disposables. In addition, we will be producing clinical nutrition and we are confident enough to state that this will be excellent.
Town of Emmen
Until 2024, we will be producing nearly a million complete autotransfusion systems and apheresis collection systems in different formats on an annual basis at our production site in Emmer-Compascuum. The systems are used by medical staff at hospitals and blood banks. In 2024, we will be relocating these activities to Fresenius Kabi in Central America.
As of 2021, our activities will also focus on the production of clinical (tube feed) nutrition and we will produce millions of high-quality clinical nutrition bags. This will ensure that this site will continue to produce high-quality products that really make a huge contribution to the wellbeing of sick people.
Autotransfusion and apheresis collection systems (APS)
Fresenius Kabi produces different medical disposables. We make a distinction between infusion and sterile solutions and blood transfusion and processing equipment.
We produce APS disposables for the following equipment:
Apheresis equipment for cell separation:
- AS 104
- AS.TEC 204/205
Autologous blood transfusion equipment for autotransfusion:
When using an apheresis machine, blood can be separated in different components when being taken from the donor. This ensures that a specific component, i.e., plasma or thrombocyte concentrate, can be taken while the other blood components, for example, erythrocytes, can be returned to the donor. A relatively large quantity of one component can thus be harvested during one donation.
The components that we produce in Emmer-Compascuum are binned after one use. We do this for the following treatments:
- Thrombocyte (platelet) separation;
- (Peripheral) stem cell separation;
- Therapeutic plasma exchange;
- Therapeutic red blood cell exchange.
Continuous Autologous Transfusion System
The C.A.T.S. is a device that has been developed to wash and separate blood. Washed red blood cells are returned (immediately) to the patient. This means that the patient does not have to receive blood from a donor (and is not exposed to all the risks that this entails). Fresenius Kabi also produces disposables for this device.
This C.A.T.S. is mainly deployed for:
- Massive haemorrhaging;
- Hip operations;
- (Liver) transplants;
- Jehovah witnesses (may not receive blood from people because of their religious beliefs).
Excellence in clinical (tube feed) nutrition
Many studies have shown that nutrition plays an important part in the recovery of patients. Clinical nutrition is therefore in the spotlight more and more often. Clinical nutrition is not medication but it is not standard food or a sports drink either. It is for people who are malnourished (or run a risk of becoming malnourished), for example, in relation to cancer, anorexia, dysphagia (swallowing difficulties) or diabetes mellitus. The body then needs extra protein and other nutrients.
Our Fresubin nutrition line
The Fresenius Kabi clinical nutrition line is called Fresubin. These products are meant to ensure that (good) body weight is maintained and/or improved. One possibility is by closing the nutritional gap between daily food intake and the body’s nutritional requirements.
We offer more than 50 choices with our broad product range of different clinical nutrition products. Our Fresubin products can be supplied in different compositions, energy and protein densities, formats and textures. Therefore there is sufficient choice. This stimulates adherence by patients who need these products.
Clinical (tube feed) nutrition
We will be producing clinical (tube feed) nutrition as of 2021 in Emmer-Compascuum. Specific clinical (tube feed) nutrition that is used for patients who cannot eat themselves (temporarily). To prevent unhealthy weight loss or to supplement this, tube feed will be administered through the stomach.
We often see the use of Fresubin with regard to:
- Patients with dysphagia who find it difficult to swallow or that cannot swallow at all.
- Patients with cancer after intensive therapies that entail many side effects such as vomiting, diarrhea or bowel movement problems.
- Patients with anorexia;
- Postoperative patients;
- Patients with gastric disorders or gastro-intestinal ailments involving weight loss;
- Chronic alcohol or drug abuse patients;
- The elderly.
If you want to learn more about clinical (tube feed) nutrition,
read also the product information about clinical nutrition.